Login to Your Account



TCM Compound for IBS, Crohn’s Enters Phase III

By Shannon Ellis
Staff Writer

Thursday, September 12, 2013
SHANGHAI – A joint venture between a Chinese and a Swiss company has launched Phase III trials for a botanical drug to treat inflammatory bowel disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription